Template:Immunohistochemistry evaluation of invasive breast cancer: Difference between revisions
Jump to navigation
Jump to search
Templated |
m Tabled |
||
| Line 1: | Line 1: | ||
===Immunohistochemistry=== | ===Immunohistochemistry=== | ||
{|class="wikitable" | |||
| | |||
*Ki-67 index: | *Ki-67 index: | ||
<gallery mode=packed heights=200> | <gallery mode=packed heights=200> | ||
| Line 14: | Line 16: | ||
|- | |- | ||
| 3+ || HER2 positive | | 3+ || HER2 positive | ||
|} | |||
|}</noinclude> | |}</noinclude> | ||
{{Bottom}} | {{Bottom}} | ||
</noinclude> | </noinclude> | ||
Revision as of 10:58, 4 October 2019
Immunohistochemistry
|
Notes
Main page
References
- ↑ 1.0 1.1 . IHC Tests (ImmunoHistoChemistry). Breastcancer.org. Retrieved on 2019-10-04. Last modified on October 23, 2015
Image sources
